Follow-The-Filings

Security · featured owners

TNGX Tango Therapeutics Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 2 Owners
  • Max 1.8%
  • $384M
  • 1 new 1 add

TNGX (Tango Therapeutics Inc.) is held in 2 featured 13F books as of 2026 Q2. Farallon Capital Management is the largest tracked holder by portfolio weight (1.8%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 1.8% (Farallon Capital Management) · not free-float ownership

  1. Farallon Capital Management Add 1.8%

Holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

History
Farallon Capital Management 2026 Q2 1.8% Add +35.0% 12,277,000 $384M History
Ron Baron - Bamco Inc. (Baron Capital) 2026 Q2 <0.01% New <0.01% 15,000 $469K History

2 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 19 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
424B5 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K/A 5.02,7.01,9.01 Filing Doc
8-K 5.02 Filing Doc
8-K 5.02,9.01 Filing Doc
424B5 Filing Doc
8-K 1.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
424B5 Filing Doc
8-K 5.07 Filing Doc
10-Q Filing Doc
8-K 2.02,5.02,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
DEFA14A Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
10-K Filing Doc
8-K 2.02,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 15 rows shown

Filed Form Detail Links
4 Period Sep 22, 2026 Filing Doc
4 Period Sep 1, 2026 Filing Doc
4 Period Aug 3, 2026 Filing Doc
4 Period Jul 1, 2026 Filing Doc
4 Period Jun 19, 2026 Filing Doc
4 Period Jun 5, 2026 · 4 forms Filing Doc
4 Period Jun 1, 2026 Filing Doc
4 Period May 1, 2026 · 2 forms Filing Doc
4 Period Apr 29, 2026 Filing Doc
4 Period Apr 15, 2026 Filing Doc
4 Period Apr 1, 2026 Filing Doc
4 Period Mar 25, 2026 Filing Doc
4 Period Mar 5, 2026 Filing Doc
4 Period Feb 25, 2026 Filing Doc
4 Period Feb 2, 2026 · 3 forms Filing Doc

Updated 5 days ago Source: SEC EDGAR submissions All on EDGAR

Financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $36.53M $42.07M $62.38M
Net income -$101.74M -$130.3M -$101.59M
Net margin * -278.5% -309.7% -162.9%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $346.54M $266.34M $353.76M
Total non-current assets * $56.03M $50.15M $44.93M
Total assets $402.57M $316.49M $398.69M
Total current liabilities $45.94M $38.17M $21.68M
Total non-current liabilities * $103.52M $78.8M $30.83M
Total equity $253.11M $199.52M $346.18M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$117.98M -$131.5M -$138.89M
Cash from investing $41.43M $86.13M -$40.86M
Cash from financing $82.41M $47.66M $222.5M
Net change in cash $5.85M $2.29M $42.75M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

Ownership over time

filing count by report period · click a bar for that quarter’s holders